Medicare Enrolled
Dr. Marina Kuperman-Beade, M.D., F.A.A.D.
MOHS-Micrographic Surgery Physician · Fall River, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kuperman-Beade from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuperman-Beade?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kuperman-Beade
Dr. Marina Kuperman-Beade is a mohs-micrographic surgery physician in Fall River, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kuperman-Beade performed 2,427 Medicare services across 1,680 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kuperman-Beade received a total of $766 from 16 pharmaceutical and/or device companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kuperman-Beade is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 43% volume in MA
$766 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,427
Medicare services
Top 43% in MA for mohs-micrographic surgery physician
1,680
Unique beneficiaries
$206
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~121 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
434 | $529 | $1,243 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
370 | $18 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
264 | $85 | $260 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 180 | $346 | $788 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
179 | $200 | $829 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
153 | $458 | $896 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
139 | $6 | $15 |
| Chemical application to prevent wound tissue regrowth A chemical agent is applied to a wound to inhibit the regrowth of tissue. This procedure focuses on the application of the substance to manage the wound bed. |
122 | $71 | $224 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
82 | $188 | $507 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
57 | $1 | $25 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
55 | $42 | $110 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
52 | $70 | $242 |
| Additional tissue block examination Microscopic examination of an additional tissue block beyond the initial five. This step is performed to analyze extra samples from the same growth. |
48 | $66 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $72 | $235 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
38 | $42 | $79 |
| Complex wound repair, 1.1-2.5 cm A surgical procedure to close a complex wound measuring between 1.1 and 2.5 centimeters on areas such as the face, neck, hands, or feet. |
37 | $163 | $715 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $46 | $142 |
| Additional Mohs surgery stage with microscopic exam This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth. |
36 | $332 | $668 |
| Complex repair of eyelid, nose, ear, or lip wound, 1.1-2.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 1.1 and 2.5 centimeters. |
21 | $195 | $600 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
20 | $168 | $550 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
19 | $40 | $100 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
16 | $142 | $290 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
12 | $194 | $600 |
| Complex repair of eyelid, nose, ear, or lip wound, 2.6-7.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 2.6 and 7.5 centimeters. |
12 | $225 | $695 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
6.8% medium
91.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$766
Total received (2018-2024)
Avg $109/year across 7 years
Top 50% in MA for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
36
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$688 (89.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$77 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$177
2023
$123
2022
$23
2021
$203
2020
$62
2019
$118
2018
$59
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$58
UCB, Inc.
$56
Verrica Pharmaceuticals Inc.
$25
GENZYME CORPORATION
$21
Sandoz Inc.
$18
Top 3 companies account for 77.9% of 2024 payments
All-time payments by company (2018-2024) ›
LEO Pharma Inc.
$176
Incyte Corporation
$100
Janssen Biotech, Inc.
$98
Genentech USA, Inc.
$82
UCB, Inc.
$70
Janssen Scientific Affairs, LLC
$43
Regeneron Healthcare Solutions, Inc.
$32
Verrica Pharmaceuticals Inc.
$25
Dermavant Sciences, Inc.
$21
GENZYME CORPORATION
$21
Sandoz Inc.
$18
Almirall LLC
$18
Aclaris Therapeutics, Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Mission Pharmacal Company
$15
Misonix Inc
$12
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
Avar · Bimzelx · Cimzia · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · Erivedge · HYRIMOZ · Ilumya · OPZELURA · PICATO · REMICADE · RHOFADE · Seysara · TREMFYA · Tremfya · VTAMA · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Mohs-micrographic surgery physicians within 10 mi
6
Per 100K population
1.0
County median income
$84,198
Nearest hospital
SOUTHCOAST HOSPITALS GROUP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kuperman-Beade is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kuperman-Beade experienced with skin growth removal and lab exam, 1-5 blocks?
Based on Medicare claims data, Dr. Kuperman-Beade performed 434 skin growth removal and lab exam, 1-5 blocks services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kuperman-Beade receive payments from pharmaceutical companies?
Yes. Dr. Kuperman-Beade received a total of $766 from 16 companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuperman-Beade's costs compare to other mohs-micrographic surgery physicians in Fall River?
Dr. Kuperman-Beade's average Medicare payment per service is $206. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuperman-Beade) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Fall River
Browse mohs-micrographic surgery physicians in Fall River ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in MA
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in MA
Which MA mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology